UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion

Olfert, JA; Penz, ED; Manns, BJ; Mishra, EK; Davies, HE; Miller, RF; Luengo-Fernandez, R; ... Rahman, NM; + view all (2016) Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion. Respirology , 22 (4) pp. 764-770. 10.1111/resp.12962. Green open access

[img]
Preview
Text
Olfert_et_al-2016-Respirology.pdf - Published version

Download (704kB) | Preview

Abstract

BACKGROUND AND OBJECTIVE: Malignant pleural effusion is associated with morbidity and mortality. A randomized controlled trial previously compared clinical outcomes and resource use with indwelling pleural catheter (IPC) and talc pleurodesis in this population. Using unpublished quality of life data, we estimate the cost-effectiveness of IPC compared with talc pleurodesis. METHODS: Healthcare utilization and costs were captured during the trial. Utility weights produced by the EuroQol Group five-dimensional three-level questionnaire and survival were used to determine quality-adjusted life-years (QALYs) gained. The incremental cost-effectiveness ratio (ICER) was calculated over the 1-year trial period. Sensitivity analysis used patient survival data and modelled additional nursing time required per week for catheter drainage. RESULTS: Utility scores, cost and QALYs gained did not differ significantly between groups. The ICER for IPC compared with talc was favorable at $US10 870 per QALY gained. IPC was less costly with a probability exceeding 95% of being cost-effective when survival was <14 weeks, and was more costly when 2-h nursing time per week was assumed for catheter drainage. CONCLUSION: IPC is cost-effective when compared with talc, although substantial uncertainty exists around this estimate. IPC appears most cost-effective in patients with limited survival. If significant nursing time is required for catheter drainage, IPC becomes less likely to be cost-effective. Either therapy may be considered as a first-line option in treating malignant pleural effusion in patients without history of prior pleurodesis, with consideration for patient survival, support and preferences.

Type: Article
Title: Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion
Location: Australia
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/resp.12962
Publisher version: http://dx.doi.org/10.1111/resp.12962
Language: English
Additional information: Copyright © 2016 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: Chest tubes, cost-effectiveness analysis, palliative care, pleural effusion malignant, pleurodesis
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute for Global Health > Infection and Population Health
URI: https://discovery.ucl.ac.uk/id/eprint/1540294
Downloads since deposit
303Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item